Human leukocyte antigen-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy: retrospective cohort study (Q57917353)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 March 2014

Language	Label	Description	Also known as
English	Human leukocyte antigen-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy: retrospective cohort study	scientific article published on 19 March 2014

Statements

scholarly article

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528218%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Human leukocyte antigen-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy: retrospective cohort study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528218%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

based on heuristic

inferred from title

B-cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528218%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Hiroyuki Takahashi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528218%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Wataru Yamamoto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528218%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Naoya Nakamura

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528218%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Naoto Tomita

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528218%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Yoshimi Ishii

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528218%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Reina Watanabe

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528218%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Hirotaka Takasaki

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528218%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Shigeki Motomura

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528218%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Shoichi Kobayashi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528218%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Tomoyuki Yokose

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528218%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Yoshiaki Ishigatsubo

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528218%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Rika Sakai

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528218%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

19 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528218%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Leukemia & Lymphoma

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528218%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528218%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

2721-2727

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528218%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528218%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

AIDS-associated non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

Immunity, Inflammation, and Cancer

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Mol

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

Cancer related inflammation: the macrophage connection

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

CD163 versus CD68 in tumor associated macrophages of classical Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

Methylation of CIITA promoter IV causes loss of HLA-II inducibility by IFN-gamma in promyelocytic cells

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

Histone deacetylase inhibitors activate CIITA and MHC class II antigen expression in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

The prognostic significance of elevated levels of serum ferritin before chemotherapy in patients with non-Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893311

21 January 2018

Identifiers

10.3109/10428194.2014.893311

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528218%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24528218%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57917353&oldid=1767175837"